11-67991783-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_030930.4(UNC93B1):c.1557C>G(p.Arg519Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.252 in 1,433,224 control chromosomes in the GnomAD database, including 45,887 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.34 ( 6376 hom., cov: 34)
Exomes 𝑓: 0.24 ( 39511 hom. )
Consequence
UNC93B1
NM_030930.4 synonymous
NM_030930.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0730
Genes affected
UNC93B1 (HGNC:13481): (unc-93 homolog B1, TLR signaling regulator) This gene encodes a protein that is involved in innate and adaptive immune response by regulating toll-like receptor signaling. The encoded protein traffics nucleotide sensing toll-like receptors to the endolysosome from the endoplasmic reticulum. Deficiency of the encoded protein has been associated with herpes simplex encephalitis. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 11-67991783-G-C is Benign according to our data. Variant chr11-67991783-G-C is described in ClinVar as [Benign]. Clinvar id is 537932.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.073 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.442 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UNC93B1 | NM_030930.4 | c.1557C>G | p.Arg519Arg | synonymous_variant | 11/11 | ENST00000227471.7 | NP_112192.2 | |
UNC93B1 | XM_011545290.1 | c.1146C>G | p.Arg382Arg | synonymous_variant | 9/9 | XP_011543592.1 | ||
UNC93B1 | XM_011545291.3 | c.1002C>G | p.Arg334Arg | synonymous_variant | 8/8 | XP_011543593.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UNC93B1 | ENST00000227471.7 | c.1557C>G | p.Arg519Arg | synonymous_variant | 11/11 | 1 | NM_030930.4 | ENSP00000227471.3 | ||
UNC93B1 | ENST00000525368.1 | n.*35C>G | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.336 AC: 42262AN: 125786Hom.: 6375 Cov.: 34
GnomAD3 genomes
AF:
AC:
42262
AN:
125786
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.122 AC: 14620AN: 119604Hom.: 1847 AF XY: 0.114 AC XY: 7370AN XY: 64878
GnomAD3 exomes
AF:
AC:
14620
AN:
119604
Hom.:
AF XY:
AC XY:
7370
AN XY:
64878
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.244 AC: 318737AN: 1307336Hom.: 39511 Cov.: 37 AF XY: 0.241 AC XY: 155403AN XY: 645510
GnomAD4 exome
AF:
AC:
318737
AN:
1307336
Hom.:
Cov.:
37
AF XY:
AC XY:
155403
AN XY:
645510
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.336 AC: 42303AN: 125888Hom.: 6376 Cov.: 34 AF XY: 0.328 AC XY: 19999AN XY: 60966
GnomAD4 genome
AF:
AC:
42303
AN:
125888
Hom.:
Cov.:
34
AF XY:
AC XY:
19999
AN XY:
60966
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 26% of patients studied by a panel of primary immunodeficiencies. Number of patients: 25. Only high quality variants are reported. - |
Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at